Resultado da pesquisa (13)

Termo utilizado na pesquisa Brum M.C.S.

#11 - Granulocyte-macrophage colony-stimulating factor does not increase the potency or efficacy of a foot-and-mouth disease virus subunit vaccine, p.150-158

Abstract in English:

Caron L., Brum M.C.S., Moraes M.P., Golde W.T., Arns C.W. & Grubman M.J. 2005. Granulocyte-macrophage colony-stimulating factor does not increase the potency or efficacy of a foot-and-mouth disease virus subunit vaccine. Pesquisa Veterinária Brasileira 25(3):150-158. USDA, ARS, PIADC-FMD Research Unit, PO.Box 848, Greenport, NY 11944 0848, USA. E-mail: mgrubman@piadc.ars.usda.gov Foot-and-mouth disease (FMD) is one of the most feared diseases of livestock worldwide. Vaccination has been a very effective weapon in controlling the disease, however a number of concerns with the current vaccine including the inability of approved diagnostic tests to reliably distinguish vaccinated from infected animals and the need for high containment facilities for vaccine production, have limited its use during outbreaks in countries previously free of the disease. A number of FMD vaccine candidates have been tested and a replication-defective human adenovirus type 5 (Ad5) vector containing the FMDV capsid (P1-2A) and 3C protease coding regions has been shown to completely protect pigs against challenge with the homologous virus (FMDV A12 and A24). An Ad5-P1-2A+3C vaccine for FMDV O1 Campos (Ad5-O1C), however, only induced a low FMDV-specific neutralizing antibody response in swine potency tests. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been successfully used to stimulate the immune response in vaccine formulations against a number of diseases, including HIV, hepatitis C and B. To attempt to improve the FMDV-specific immune response induced by Ad5-O1C, we inoculated swine with Ad5-O1C and an Ad5 vector containing the gene for porcine GM-CSF (pGM-CSF). However, in the conditions used in this trial, pGM-CSF did not improve the immune response to Ad5-O1C and adversely affected the level of protection of swine challenged with homologous FMDV.

Abstract in Portuguese:

Caron L., Brum M.C.S., Moraes M.P., Golde W.T., Arns C.W. & Grubman M.J. 2005. Granulocyte-macrophage colony-stimulating factor does not increase the potency or efficacy of a foot-and-mouth disease virus subunit vaccine. Pesquisa Veterinária Brasileira 25(3):150-158. USDA, ARS, PIADC-FMD Research Unit, PO.Box 848, Greenport, NY 11944 0848, USA. E-mail: mgrubman@piadc.ars.usda.gov Foot-and-mouth disease (FMD) is one of the most feared diseases of livestock worldwide. Vaccination has been a very effective weapon in controlling the disease, however a number of concerns with the current vaccine including the inability of approved diagnostic tests to reliably distinguish vaccinated from infected animals and the need for high containment facilities for vaccine production, have limited its use during outbreaks in countries previously free of the disease. A number of FMD vaccine candidates have been tested and a replication-defective human adenovirus type 5 (Ad5) vector containing the FMDV capsid (P1-2A) and 3C protease coding regions has been shown to completely protect pigs against challenge with the homologous virus (FMDV A12 and A24). An Ad5-P1-2A+3C vaccine for FMDV O1 Campos (Ad5-O1C), however, only induced a low FMDV-specific neutralizing antibody response in swine potency tests. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been successfully used to stimulate the immune response in vaccine formulations against a number of diseases, including HIV, hepatitis C and B. To attempt to improve the FMDV-specific immune response induced by Ad5-O1C, we inoculated swine with Ad5-O1C and an Ad5 vector containing the gene for porcine GM-CSF (pGM-CSF). However, in the conditions used in this trial, pGM-CSF did not improve the immune response to Ad5-O1C and adversely affected the level of protection of swine challenged with homologous FMDV.


#12 - Fetal protection against challenge with bovine viral diarrhea vírus (BVDV) in pregnant ewes immunized with two strains experimentally attenuated, 22(2):64-72

Abstract in English:

ABSTRACT.- Brum M.C.S., Weiblen R., Flores E.F, Tobias F.L., Pituco E.M. & Winkelmann E.R. 2002. [Fetal protection against challenge with bovine viral diarrhea vírus (BVDV) in pregnant ewes immunized with two strains experimentally attenuated.] Proteção fetal frente a desafio com o vírus da Diarréia Viral Bovina (BVDV) em ovelhas prenhes imunizadas com duas amostras de vírus atenuadas experimentalmente. Pesquisa Veterinária Brasileira 22(2):64-72. Depto Medicina Veterinária Preventiva, Centro de Ciências Rurais, Universidade Federal de Santa Maria (DMVP/CCR/UFSM), Santa Maria, RS 97105-900, Brazil. E-mail: flores@ccr.ufsm.br Two isolates of bovine viral diarrhea virus (BVDV) submitted to multiple passages in tissue culture associated with ultraviolet irradiation were evaluated as vaccine virus candidates. The attenuation of the modified viruses was assessed in calves and in pregnant ewes. Intramuscular inoculation of the viruses in four seronegative calves produced only a mil d and transient rise in body temperature, followed by the production of high titers of neutralizing antibodies. The viruses were not detected in nasal secretions or in the blood following inoculation. However, intramuscular inoculation of these viruses in four pregnant ewes resulted in transplacental transmission and infection of ali fetuses. To assess fetal protection conferred by immunization, pregnant ewes immunized twice with the modified viruses were subsequently challenged by intranasal inoculation of BVDV-1 (SV-126.8, n=6) or BVDV-2 (SV-260, n=5). At the day of challenge (134 days after the second immunization), ali ewes had high titers of neutralizing antibodies (256 to >4096) to the vaccine viruses and variable titers (8 to >4096) to Brazilian BVDV-1 and BVDV-2 field isolates. Fifteen days after challenge, the ewes were euthanized and fetal tissues were examined for infectivity. Ali fetuses from non-vaccinated, challenged ewes (n=4) were infected. In contrast, none of the fetuses from the immunized dams (n = 11) were positive for virus, indicating that the immunological response induced by immunization with the vaccine candidate viruses was capable of preventing fetal infection. These results indicate that it is possible to achieve fetal protection to BVDV by induction of a strong immunological response using modified live vaccines.

Abstract in Portuguese:

RESUMO.- Brum M.C.S., Weiblen R., Flores E.F, Tobias F.L., Pituco E.M. & Winkelmann E.R. 2002. [Fetal protection against challenge with bovine viral diarrhea vírus (BVDV) in pregnant ewes immunized with two strains experimentally attenuated.] Proteção fetal frente a desafio com o vírus da Diarréia Viral Bovina (BVDV) em ovelhas prenhes imunizadas com duas amostras de vírus atenuadas experimentalmente. Pesquisa Veterinária Brasileira 22(2):64-72. Depto Medicina Veterinária Preventiva, Centro de Ciências Rurais, Universidade Federal de Santa Maria (DMVP/CCR/UFSM), Santa Maria, RS 97105-900, Brazil. E-mail: flores@ccr.ufsm.br Duas amostras do vírus da Diarréia Viral Bovina (BVDV) submetidas a múltiplas passagens em cultivo celular e exposição à radiação ultravioleta (UV) a cada passagem foram avaliadas como candidatos a vírus vacinais. As amostras foram testadas quanto à sua atenuação para bezerros e fetos ovinos, reatividade antigênica contra isolados de campo, e capacidade de induzir proteção fetal em ovelhas prenhes. Inoculação intramuscular (IM) dos vírus modificados em quatro bezerros produziu apenas uma elevação discreta e passageira da temperatura corporal, seguida de produção de altos títulos de anticorpos neutralizantes. O vírus não foi detectado em secreções nasais ou sangue nos dias seguintes à inoculação. Porém, a inoculação IM desses vírus em quatro ovelhas prenhes foi seguida de transmissão transplacentária e infecção em todos os fetos. Para os testes de proteção fetal, ovelhas prenhes previamente imunizadas com duas doses vacinais, foram inoculadas por via intranasal com amostras de BVDV-1 (SV-126.8, n=6) ou BVDV-2 (SV-260, n=5). No dia do desafio (134 dias após a segunda dose), todos os animais apresentavam altos títulos de anticorpos neutralizantes (256 a >4096) contra os vírus vacinais; além de títulos variados (8 a >4096) contra várias isolados brasileiros de BVDV-1 e BVDV-2. Quinze dias após o desafio, as ovelhas foram sacrificadas e os tecidos fetais foram examinados para a presença de vírus. Todos os fetos das ovelhas controle não-vacinadas apresentaram-se (n=4) positivos para os vírus utilizados no desafio. Em contraste, nenhum feto das ovelhas imunizadas (n = 11) foi positivo para vírus, indicando que a resposta imunológica induzida pela vacinação com os vírus modificados foi capaz de prevenir a infecção fetal. Estes resultados indicam que é possível obter-se forte resposta imunológica e proteção fetal contra o BVDV com o uso de vacinas vivas modificadas.


#13 - Acute and Iatent infection in sheep inoculated with bovine herpesvirus type-5 (BHV-5), 18(3/4):99-106

Abstract in English:

ABSTRACT.- Silva A.M., Flores E.F., Weiblen R., Botton S.A., lrigoyen L.F., Roehe P.M., Brum M.C.S. & Canto M.C. 1998. [Acute and Iatent infection in sheep inoculated with bovine herpesvirus type-5 (BHV-5).] Infecção aguda e latente em ovinos inoculados com o herpesvírus bovino tipo 5 (BHV-5). Pesquisa Veterinária Brasileira 18(3/4):99-106. Depto Medicina Veterinária Preventiva, Universidade Federal de Santa Maria, 97015-900 Santa Maria, RS, Brazil. Experimental inoculation of lambs with bovine herpesvirus type 5 (BHV-5) reproduced several aspects of the BHV-5 infection in cattle. lntranasal inoculation was followed by eficiente viral replication and shedding, establishment and reactivation of latency, and even the development of meningoencephalitis in one animal. Lambs inoculated with the brazilian is o late EVl-88 showed transient hipertermia, nasal hiperemia and discharge ranging from serous to muco purulent. The animals shed virus in nasal secretions in titers up to 107,11 TCID50/ml during up to 16 days. One lamb showed clinical signs of encephalitis on day 10 post inoculation (pi), being euthanized in extremis on day 13. lnfectious vírus was recovered from severa) áreas of the brain of this lamb, including anterior and posterior cerebrum, dorso- and ventro-lateral hemisphere, cerebellum, pons, midbrain and olfactory bulb. Histological changes were observed in severa) regions of the brain, most consistently in the anterior cerebrum, ventrolateral cortex and midbrain, and consisted mainly of meningitis, perivascular mononuclear cuffing, focal gliosis, neuronal necrosis and intranuclear inclusions. Four lambs used as sentinels acquired the infection and shed virus starting at the 2nd day pi during up to 7 days. Lambs inoculated with the argentinian isolate A663 showed only mild respiratory signs, although they shed virus for up to 15 days. Administration of dexamethazone to the animals starting at day 50 pi was followed by reactivation of the latent infection and viral shedding during up to 11 days by 76.9% (10/13) of the inoculated lambs and 100% (3/3) of the sentinels. These results demonstrate that sheep are susceptible to BHV-5 acute and latent infection and suggest that natural infections by this virus in sheep may potentially occur. ln this sense, a possible role of this species in the epidemiology of BHV-5 infections awaits further investigation.

Abstract in Portuguese:

RESUMO.- Silva A.M., Flores E.F., Weiblen R., Botton S.A., lrigoyen L.F., Roehe P.M., Brum M.C.S. & Canto M.C. 1998. [Acute and Iatent infection in sheep inoculated with bovine herpesvirus type-5 (BHV-5).] Infecção aguda e latente em ovinos inoculados com o herpesvírus bovino tipo 5 (BHV-5). Pesquisa Veterinária Brasileira 18(3/4):99-106. Depto Medicina Veterinária Preventiva, Universidade Federal de Santa Maria, 97015-900 Santa Maria, RS, Brazil. Infecção experimental de ovinos com o herpesvírus bovino tipo 5 (BHV-5) reproduziu vários aspectos da infecção pelo BHV-5 em bovinos. Inoculação intranasal foi seguida de extensiva replicação virai na cavidade nasal, excreção e transmissão do vírus a outros. animais, estabelecimento e reativação de latência, e o desenvolvimento de meningoencefalite clínica em um animal. Ovinos inoculados com a amostra brasi- leira EVl-88 apresentaram hipertermia transitória, hiperemia da mucosa nasal e corrimento nasal de seroso a muco-purulento. Os animais eliminaram vírus em secreções nasais em títulos de até 107,11 DICC50/ml por até 16 dias. Um cordeiro apresentou sinais clínicos de encefalite no dia 10 pósinoculação, sendo sacrificado in extremis no início do dia 13. Infectividade foi detectada em várias regiões do encéfalo des: se animal, incluindo os hemisférios anterior e posterior, córtex orso- e ventro-lateral, ponte, pedúnculo cerebral, cerebelo e bulbo olfatório. Alterações histológicas foram observadas em várias regiões do encéfalo, principalmente no hemisfério anterior, córtex ventro-lateral e pedúnculos cerebrais, e consistiram de meningite mononuclear, manguitos perivasculares, gliose focal, necrose e inclusões intranucleares em neurônios. Quatro ovinos mantidos como sentinelas adquiriram a infecção e eliminaram vírus a partir do final do segundo dia, até 7 dias. Ovinos inoculados com a amostra argentina A663 apresentaram apenas hiperemia e umidecimento da mucosa nasal, embora eliminassem vírus nas secreções nasais por até 15 dias. Tratamento dos animais com dexametasona a partir do dia 50 pós-inoculação provocou reativação da infecção latente e eliminação viral durante até 11 dias por 76,9% (10/13) dos animais inoculados e por 100% (3/3) dos animais sentinela. Esses resultados·demonstram que ovinos são susceptíveis à infecção aguda e latente pelo BHV-5 e sugerem que infecções naturais de ovinos por este vírus podem potencialmente ocorrer. Ness sentido, uma possível participação da espécie ovina como reservatório natural desse vírus deve ser melhor investigada.


Colégio Brasileiro de Patologia Animal SciELO Brasil CAPES CNPQ UNB UFRRJ CFMV